Figure 3From: Morning and evening behavior in children and adolescents treated with atomoxetine once daily for Attention-Deficit/Hyperactivity Disorder (ADHD): Findings from two 24-week, open-label studiesWREMB-R evening and morning subscores over time (means and 95% CIs, LOCF data). The two scalings reflect the different number of items of the evening (8 items) and morning (3 items) subscores.Back to article page